Cellectis (CLLS) Profit After Tax (2015 - 2026)
Cellectis' (CLLS) quarterly Profit After Tax came in at -$17.8 million in Q1 2026, up 2.0% year-on-year from -$17.4 million in Q1 2025, and up 32.5% quarter-over-quarter from -$26.3 million in Q4 2025.
Cellectis (CLLS) Profit After Tax (2015 - 2026) Analysis & Trends
Cellectis' Profit After Tax history runs 12 years deep, the most recent figure standing at -$17.8 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 2.0% year-over-year to -$17.8 million in Q1 2026; TTM through Mar 2026 was -$67.2 million, a 11.07% decrease from a year earlier, with the FY2025 full-year figure at -$67.6 million, down 83.87% from the prior year.
- Profit After Tax advanced to -$17.8 million in Q1 2026 per CLLS's latest filing, from -$26.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at $5.9 million in Q4 2024 and bottomed at -$41.8 million in Q4 2023.
- The 5-year median for Profit After Tax is -$23.1 million (2024), against an average of -$20.3 million.
- Across the five-year window, Profit After Tax soared 117.35% in 2024 and tumbled 544.41% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$28.6 million in 2022, then sank by 46.35% to -$41.8 million in 2023, then soared by 114.17% to $5.9 million in 2024, then tumbled by 544.41% to -$26.3 million in 2025, then jumped by 32.5% to -$17.8 million in 2026.
- Per Business Quant, the three latest CLLS Profit After Tax figures stand at -$17.8 million (Q1 2026), -$26.3 million (Q4 2025), and $589000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.77 Mn |
| Dec 31, 2025 | -26.32 Mn |
| Sep 30, 2025 | 589,000.00 |
| Jun 30, 2025 | -23.74 Mn |
| Mar 31, 2025 | -18.13 Mn |
| Dec 31, 2024 | 5.92 Mn |
| Sep 30, 2024 | -23.06 Mn |
| Jun 30, 2024 | -25.27 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Dec 31, 2023 | -41.80 Mn |
| Sep 30, 2023 | -17.48 Mn |
| Jun 30, 2023 | -16.64 Mn |
| Mar 31, 2023 | -32.53 Mn |
| Dec 31, 2022 | -28.56 Mn |
| Sep 30, 2022 | -31.27 Mn |
| Jun 30, 2022 | -19.45 Mn |
| Mar 31, 2022 | -34.76 Mn |
| Dec 31, 2021 | -28.08 Mn |
| Sep 30, 2021 | -40.07 Mn |
| Jun 30, 2021 | -41.61 Mn |